• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Microbiol . Defective Viral Particles Produced in Mast Cells Can Effectively Fight Against Lethal Influenza A Virus

tetano

Editor, Senior Moderator
Front Microbiol


. 2020 Nov 4;11:553274.
doi: 10.3389/fmicb.2020.553274. eCollection 2020.
Defective Viral Particles Produced in Mast Cells Can Effectively Fight Against Lethal Influenza A Virus


Caiyun Huo[SUP] 1 [/SUP], Jinlong Cheng[SUP] 1 [/SUP], Jin Xiao[SUP] 2 [/SUP], Mingyong Chen[SUP] 1 [/SUP], Shumei Zou[SUP] 3 [/SUP], Haiyan Tian[SUP] 1 [/SUP], Ming Wang[SUP] 1 [/SUP], Lunquan Sun[SUP] 4 [/SUP], Zhihui Hao[SUP] 1 [/SUP], Yanxin Hu[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

Mast cells play an important role in the pathogenesis of highly pathogenic H5N1 avian influenza virus (H5N1-HPAIV) infection. Defective viral particles (DPs) can interfere with the replication of infectious viruses and stimulate the innate immune response of host cells. However, DPs arising from mast cells during HPAIV replication and their potent antiviral actions has not been reported. Here, we showed that the human mastocytoma cell line, HMC-1, allowed for the productive replication of the H5N1-HPAIV. Compared with alveolar cell line A549, DPs were propagated preferentially and abundantly in mast cells following IAV infection, which can be attributed to the wide existence of Argonaute 2 (AGO2) in HMC-1 cells. In addition, DPs generated in H5N1-infected cells could provide great therapeutic protection on mice to fight against various influenza A viruses, which included not only homologous H5N1-HPAIV, but also heterologous H1N1, H3N2, H7N2, and H9N2. Importantly, DPs generated in H5N1-infected HMC-1 cells could diminish viral virulence in vivo and in vitro by triggering a robust antiviral response through type II interferon signaling pathways. This study is the first to illustrate the arising of DPs in H5N1-HPAIV infected mast cells and explore their favorable ability to protect mice from influenza A viruses infection, which provides a novel insight and valuable information for the progress of new strategies to fight influenza A viruses infection, especially highly pathogenic avian influenza virus infection by focusing on the DPs generated in mast cells.

Keywords: defective viral particles; highly pathogenic H5N1 avian influenza virus; interferon signaling pathway; mast cells; therapeutic protection.
 
Back
Top Bottom